LOGIN
Long-term safety and effectiveness of tanezumab 10 mg vs. 20 mg for chronic low back pain
December 2016
Long-term safety and effectiveness of tanezumab 10 mg vs. 20 mg for chronic low back pain
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain
Pain. 2014 Sep;155(9):1793-801.Synopsis
849 patients with chronic low back pain (equal or > 3 months) were randomized to receive three intravenous injections of 10 mg or 20 mg of tanezumab followed by up to 4 subcutaneous injections every 8 weeks. This extension study aimed to compare the long-term safety and effectiveness of two different tanezumab doses. Ten and 20 mg doses of tanezumab produced similar effectiveness outcomes at 24 we...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.